{"gene":"CMKLR1","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1996,"finding":"CMKLR1 encodes a seven-transmembrane G protein-linked receptor with sequence homology to chemokine receptors, expressed in hematopoietic and immune tissues; chromosomal localization to 12q24.1 established by FISH.","method":"Molecular cloning, FISH chromosomal mapping, Northern blot expression profiling","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 — original cloning paper with structural characterization, single lab","pmids":["8976386"],"is_preprint":false},{"year":1998,"finding":"ChemR23 (CMKLR1) is expressed in monocyte-derived dendritic cells and macrophages and functions as a coreceptor for SIV and some primary HIV-1 strains in cell fusion assays.","method":"RT-PCR expression profiling, cell fusion coreceptor assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional fusion assay, single lab, replicated across multiple viral strains","pmids":["9603476"],"is_preprint":false},{"year":2003,"finding":"TIG2/chemerin (residues 21–154 of the prepropeptide) was identified as the natural ligand of ChemR23 (CMKLR1) via reverse pharmacology screening of peptide libraries from human hemofiltrate.","method":"Reverse pharmacology peptide library screening, receptor binding assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical identification of endogenous ligand using receptor binding","pmids":["14675762"],"is_preprint":false},{"year":2005,"finding":"ChemR23 (CMKLR1) is expressed and functional in plasmacytoid and myeloid dendritic cells; recombinant chemerin induces transmigration of these DCs across endothelial monolayers, and ChemR23+ DCs localize near chemerin-expressing high endothelial venules in lymphoid organs.","method":"Flow cytometry, transendothelial migration assay, immunohistochemistry, co-localization","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, functional migration assay, in vivo localization","pmids":["15728234"],"is_preprint":false},{"year":2007,"finding":"RvE1 binds specifically to ChemR23 (CMKLR1) on human PMNs (Kd ~48 nM); RvE1 also binds recombinant BLT1 (Kd 45 nM) and acts as a partial agonist at BLT1, inhibiting adenylate cyclase and NF-κB activation, while its anti-inflammatory actions at higher doses involve ChemR23-mediated counterregulatory mechanisms.","method":"[3H]RvE1 radioligand binding assay, adenylate cyclase assay, NF-κB reporter assay, BLT1 knockout mouse peritonitis model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct radioligand binding with Kd determination, multiple functional assays, in vivo KO validation","pmids":["17339491"],"is_preprint":false},{"year":2008,"finding":"Chemerin requires proteolytic processing of its C-terminus for anti-inflammatory activity; the C-terminal peptide chemerin15 (A140–A154) suppresses macrophage activation and peritonitis at picomolar concentrations in a ChemR23-dependent manner, as shown by complete loss of activity in ChemR23−/− mice.","method":"In vitro macrophage activation assay, zymosan peritonitis model, ChemR23 knockout mice","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro and in vivo with KO confirmation, multiple orthogonal methods","pmids":["18391062"],"is_preprint":false},{"year":2009,"finding":"Mouse ChemR23 mediates chemerin-induced calcium mobilization and chemotaxis in dendritic cells and macrophages; these responses are abrogated in ChemR23 knockout mice. Chemerin reduces neutrophil infiltration and inflammatory cytokine release in LPS-induced lung inflammation in a ChemR23-dependent manner.","method":"Calcium mobilization assay, chemotaxis assay, ChemR23 KO mice, LPS-induced lung inflammation model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple functional assays with KO confirmation, in vivo and in vitro","pmids":["19841182"],"is_preprint":false},{"year":2009,"finding":"Chemerin/CMKLR1 signaling is required for adipocyte differentiation of bone marrow stromal cells; RNAi knockdown of chemerin or CMKLR1 abrogates adipogenesis and clonal expansion, while increasing osteoblast marker expression and mineralization; PPARγ-induced chemerin expression partially rescues adipogenesis.","method":"RNAi knockdown, differentiation assays, PPARγ overexpression rescue experiment","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with specific cellular phenotype, rescue experiment, multiple cell types","pmids":["19929432"],"is_preprint":false},{"year":2009,"finding":"Chemerin activates ChemR23 in human endothelial cells, inducing angiogenesis through activation of PI3K/Akt and MAPK signaling pathways, and dose-dependently increases MMP-2 and MMP-9 gelatinolytic activity.","method":"In vitro angiogenesis assays (tube formation, migration), phosphorylation western blot, zymography","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — functional assays with signaling, single lab, no ChemR23 KO confirmation","pmids":["20044979"],"is_preprint":false},{"year":2010,"finding":"Chemerin15 enhances macrophage phagocytosis of microbial particles and efferocytosis of apoptotic cells via ChemR23, associated with increased actin polymerization and F-actin localization to the phagocytic cup; these effects require Syk kinase activity and are absent in ChemR23−/− macrophages.","method":"Phagocytosis assays, ChemR23 KO macrophages, Syk inhibitor, actin polymerization assay, in vivo peritonitis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — KO confirmation, pharmacological inhibition, in vitro and in vivo, multiple orthogonal readouts","pmids":["20363975"],"is_preprint":false},{"year":2010,"finding":"Chemerin binding to ChemR23 in human articular chondrocytes induces phosphorylation of ERK1/2 and Akt, and promotes secretion of pro-inflammatory cytokines (IL-6, IL-8, TNF-α, IL-1β) and matrix metalloproteases (MMP-1, -2, -3, -8, -13).","method":"Phosphorylation western blot, ELISA cytokine quantification, cell stimulation assay","journal":"Arthritis research & therapy","confidence":"Medium","confidence_rationale":"Tier 3 — functional signaling assays, single lab, no receptor KO confirmation","pmids":["21192818"],"is_preprint":false},{"year":2011,"finding":"ChemR23 knockout mice show increased neutrophilic infiltration, delayed viral clearance, and higher mortality in pneumonia virus of mice infection; ChemR23 recruits plasmacytoid DCs to promote type I interferon production and adaptive immune responses, while ChemR23 on non-leukocytic cells provides a separate anti-inflammatory function.","method":"ChemR23 KO mice, depletion/adoptive transfer of pDCs, chimeric mice, lung function measurement, interferon quantification","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic tools, adoptive transfer epistasis, in vivo mechanistic dissection","pmids":["22072972"],"is_preprint":false},{"year":2011,"finding":"CMKLR1-deficient mice show reduced adiposity, lower food consumption, decreased adipose/hepatic inflammation, and glucose intolerance with impaired glucose-stimulated insulin secretion and reduced skeletal muscle/adipose tissue glucose uptake, demonstrating CMKLR1's role in adipose development, inflammation, and glucose homeostasis.","method":"CMKLR1 KO mouse model, body composition analysis, glucose/insulin tolerance tests, immune cell profiling, glucose uptake assay","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — comprehensive KO phenotyping with multiple orthogonal readouts","pmids":["22186410"],"is_preprint":false},{"year":2013,"finding":"ChemR23 is expressed in neutrophil granules and is upregulated upon neutrophil activation; chemerin15 inhibits integrin activation and clustering via ChemR23, reducing neutrophil adhesion and chemotaxis in vitro and inducing detachment of adherent neutrophils from inflamed endothelium, reducing heart damage in a murine myocardial infarction model.","method":"Flow cytometry, integrin activation assay, intravital microscopy, murine MI model, ChemR23 KO","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — mechanistic in vitro plus in vivo with KO, multiple assays","pmids":["23999103"],"is_preprint":false},{"year":2014,"finding":"The small molecule α-NETA inhibits chemerin-stimulated β-arrestin2 association with CMKLR1 and blocks chemerin-triggered CMKLR1+ cell migration, acting as a CMKLR1 antagonist; α-NETA delays EAE onset and reduces CNS mononuclear cell infiltrates.","method":"β-arrestin2 recruitment assay, chemotaxis assay, EAE mouse model (active immunization and adoptive transfer)","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — direct receptor signaling assay plus in vivo pharmacological validation","pmids":["25437209"],"is_preprint":false},{"year":2015,"finding":"Chemerin signals through CMKLR1 via the RhoA/ROCK pathway to activate the transcriptional regulator SRF; RhoA, ROCK, p38, and Gαi/o signaling are all required for chemerin-mediated chemotaxis; GPR1 is confirmed as a functional chemerin receptor with similar but distinct signaling properties.","method":"Luciferase reporter assays, pathway-specific inhibitors, chemotaxis assay, CMKLR1/GPR1 transfection","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple inhibitors and reporter assays, single lab","pmids":["26363224"],"is_preprint":false},{"year":2015,"finding":"Aβ42 binds specifically to CMKLR1 in stably transfected RBL cells; Aβ42 induces CMKLR1-dependent cell migration through ERK1/2, PKA, and Akt pathways (but not Ca2+ mobilization), and CMKLR1 mediates internalization of the Aβ42-CMKLR1 complex in primary glial cells.","method":"Radioligand-like specific binding in transfected cells, migration assays, signaling pathway inhibitors, internalization assay","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay plus functional KD/KO comparison, single lab","pmids":["25079809"],"is_preprint":false},{"year":2015,"finding":"ChemR23 expression is regulated at the transcriptional level; M1 macrophages (stimulated by LPS or IFN-γ) upregulate ChemR23 from promoter P3, are chemotactic to chemerin, and are repolarized toward a resolution phenotype by RvE1 through ChemR23, increasing IL-10 and phagocytosis; M2 macrophages do not express surface ChemR23.","method":"5' RACE, promoter analysis, FACS, chemotaxis assay, RvE1 stimulation, phagocytosis assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, mechanistic transcriptional and functional characterization","pmids":["25637017"],"is_preprint":false},{"year":2016,"finding":"Chemerin binding to CMKLR1 activates all three Gαi subtypes (Gαi1, Gαi2, Gαi3) and both Gαo isoforms (Gαoa, Gαob), recruits β-arrestin1 and β-arrestin2, and induces receptor internalization and ERK1/2 phosphorylation; ERK1/2 phosphorylation requires both Gαi/o and β-arrestin2 activation but not β-arrestin1.","method":"BRET-based G protein activation biosensors, β-arrestin recruitment assay, receptor internalization assay, ERK phosphorylation western blot","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 — BRET biosensors with multiple G protein subtypes, multiple orthogonal signaling assays","pmids":["27716822"],"is_preprint":false},{"year":2017,"finding":"The IUPHAR nomenclature review confirmed that chemerin activates CMKLR1 (Chemerin1) via Gi/o coupling causing inhibition of adenylyl cyclase and increased Ca2+ flux; human chemerin21-157 is the most active form; CCX832 selectively blocks CMKLR1; resolvin E1 also activates CMKLR1.","method":"Pharmacological review integrating radioligand binding, cAMP, Ca2+ assays from multiple labs","journal":"Pharmacological reviews","confidence":"High","confidence_rationale":"Tier 1 — authoritative review synthesizing multiple independent biochemical measurements","pmids":["29279348"],"is_preprint":false},{"year":2018,"finding":"Targeted deletion of ERV1/ChemR23 in hyperlipidemic mice increases oxidized LDL uptake, reduces phagocytosis, and enlarges atherosclerotic plaques; resolvin E1-mediated effects on oxLDL uptake and phagocytosis in macrophages are dependent on ERV1/ChemR23 signaling.","method":"Erv1/ChemR23 KO × Apoe−/− mice, atherosclerosis histology, macrophage phagocytosis/oxLDL uptake assays, lipidomics","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — two independent hyperlipidemic mouse models, direct mechanistic assays in macrophages","pmids":["29739755"],"is_preprint":false},{"year":2018,"finding":"Chemerin activates CMKLR1 in oesophageal squamous cancer cells, increasing MMP-1, MMP-2, and MMP-3 abundance and activity through protein kinase C and p44/42 MAPK pathways, promoting cancer cell invasion; the ChemR23 antagonist CCX832 inhibits this invasion.","method":"Boyden chamber invasion assays, organotypic assays, siRNA, immunoneutralisation, CCX832 antagonist, western blot/enzyme assay for MMPs","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods and receptor specificity confirmed with antagonist and siRNA, single lab","pmids":["27092781"],"is_preprint":false},{"year":2018,"finding":"Chemerin-activated CMKLR1 signaling in inflammatory macrophages is regulated by GRK6 phosphorylation and β-arrestin 2 recruitment; GRK6- and β-arrestin 2-deficient macrophages show decreased CMKLR1 internalization following chemerin stimulation, increased migration toward chemerin, and altered AKT and ERK signaling.","method":"GRK6 and β-arrestin 2 KO mouse macrophages, receptor internalization assay, co-expression of GRK6 with CMKLR1, chemotaxis assay, AKT/ERK western blot","journal":"Molecular immunology","confidence":"High","confidence_rationale":"Tier 2 — two KO models, direct internalization assay, mechanistic signaling dissection","pmids":["30576947"],"is_preprint":false},{"year":2019,"finding":"Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1 by upregulating PTEN expression and phosphatase activity via interference with PTEN-CMKLR1 interaction, reducing PTEN ubiquitination and decreasing p-Akt (Ser473); CMKLR1 knockdown abolishes chemerin-induced PTEN/Akt modulation.","method":"Co-immunoprecipitation, RNAi knockdown, phosphatase activity assay, ubiquitination assay, in vivo xenograft","journal":"British journal of cancer","confidence":"High","confidence_rationale":"Tier 1–2 — Co-IP for physical interaction, biochemical phosphatase assay, in vivo rescue, multiple methods","pmids":["29717200"],"is_preprint":false},{"year":2019,"finding":"ChemR23 deletion in smooth muscle cells prevents phenotypic switching to a synthetic/osteoblastic state; ChemR23-deficient VSMCs are resistant to phosphate-induced calcification; resolvin E1 inhibits VSMC calcification through ChemR23; ChemR23-deficient mice are protected against vitamin D3-induced vascular calcification.","method":"ChemR23 KO mouse VSMCs, in vitro calcification assay, in vivo calcification model, Fat-1 transgene epistasis","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 — genetic KO, in vitro and in vivo, ligand rescue, multi-model validation","pmids":["30597013"],"is_preprint":false},{"year":2019,"finding":"ChemR23-deficient pDCs exhibit reduced migratory capacity and decreased CCR7 expression; adoptive transfer of WT vs. ChemR23 KO pDCs into Apoe−/− mice shows reduced accumulation of ChemR23-deficient pDCs in atherosclerotic lesions; hematopoietic ChemR23 deficiency increases M2 macrophage proportion and cholesterol efflux in atherosclerotic plaques.","method":"ChemR23 KO knockin eGFP mice, adoptive pDC transfer, bone marrow chimeras, atherosclerosis histology, cholesterol efflux assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — adoptive transfer epistasis, multiple genetic models, mechanistic cell assays","pmids":["30786742"],"is_preprint":false},{"year":2019,"finding":"Chemerin reduces neuronal apoptosis after neonatal hypoxic-ischemic encephalopathy via ChemR23/CAMKK2/AMPK signaling; specific inhibition of ChemR23, CAMKK2, or AMPK abolishes the anti-apoptotic effects of recombinant chemerin.","method":"Rat HIE model, intranasal chemerin administration, specific inhibitors, western blot for phospho-CAMKK2/AMPK, TUNEL/Fluoro-Jade staining","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo with pharmacological pathway inhibition at each step, single lab","pmids":["30718467"],"is_preprint":false},{"year":2020,"finding":"Chemerin/CMKLR1 axis promotes inflammation and pyroptosis in diabetic cardiomyopathy through NLRP3 inflammasome activation; CMKLR1 siRNA knockdown in vivo attenuates NLRP3, activated caspase-1, and IL-1β; in vitro, silencing either CMKLR1 or NLRP3 suppresses pyroptosis.","method":"siRNA knockdown in vivo and in vitro, NLRP3 KD double knockdown, LDH release, caspase-1 western blot, EthD-III staining","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via double knockdown, multiple functional readouts, single lab","pmids":["32390873"],"is_preprint":false},{"year":2020,"finding":"Exogenous chemerin exposure upregulates PTEN expression/activity and suppresses PD-L1 expression in human prostate and sarcoma tumor lines through CMKLR1; CMKLR1 knockdown abolishes these effects; signaling proceeds through PI3K/AKT/mTOR pathway; forced chemerin expression in DU145 xenografts suppresses tumor growth with increased PTEN and decreased PD-L1 in vivo.","method":"siRNA knockdown, specific PI3K/AKT/mTOR inhibitors, western blot, in vivo xenograft, T-cell cytotoxicity assay","journal":"Clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 — receptor KD to establish necessity, in vitro signaling + in vivo validation, multiple cell lines","pmids":["32605911"],"is_preprint":false},{"year":2020,"finding":"Abrogation of ChemR23 in Apoe−/− Fat-1tg mice abolishes the protective effects of endogenous omega-3 fatty acids on aortic valve calcification; resolvin E1 acts as a calcification inhibitor and its receptor ChemR23 is required for n-3 PUFA-mediated valve protection.","method":"ChemR23 KO × Fat-1tg × Apoe−/− mouse model, valvular lipidomics, echocardiography, histology","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with triple-cross model, multiple functional readouts","pmids":["32506925"],"is_preprint":false},{"year":2021,"finding":"The chemerin-CMKLR1 axis in adipocytes suppresses beige adipocyte-derived IL-33 by dampening cAMP-PKA signaling, thereby interrupting the feed-forward circuit between beige adipocytes and type 2 innate immunity required for cold-induced thermogenesis; adipocyte-specific CMKLR1 deletion enhances thermogenesis and protects against diet-induced obesity.","method":"Adipocyte-specific CMKLR1 KO mice, cold exposure, cAMP/PKA signaling assays, IL-33 quantification, innate immune cell profiling, diet-induced obesity model","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO, mechanistic signaling pathway delineation, multiple in vivo readouts","pmids":["34330814"],"is_preprint":false},{"year":2021,"finding":"An agonist anti-ChemR23 monoclonal antibody that induces receptor signaling promotes macrophage efferocytosis and reduces neutrophil apoptosis at the site of inflammation; it accelerates resolution of acute inflammation and triggers resolution in chronic colitis models.","method":"Agonist mAb characterization, macrophage efferocytosis assay, neutrophil apoptosis assay, acute peritonitis model, chronic colitis mouse model","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — agonist antibody with defined mechanism, multiple in vitro and in vivo models","pmids":["33811066"],"is_preprint":false},{"year":2022,"finding":"Chemerin enhances mesenchymal features of glioblastoma via CMKLR1 by suppressing ubiquitin-proteasomal degradation of CMKLR1, thereby enhancing NF-κB pathway activation; chemerin promotes TAM recruitment and M2 polarization via CMKLR1/NF-κB axis, which further drives GBM mesenchymal phenotype.","method":"CMKLR1 ubiquitination/degradation assay, NF-κB reporter assay, TAM co-culture, GBM xenograft, α-NETA pharmacological blockade","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway with ubiquitination assay, in vivo validation, single lab","pmids":["35459783"],"is_preprint":false},{"year":2022,"finding":"ChemR23 agonists RvE1 and chemerin-9 ameliorate diabetes-associated cognitive impairment by inhibiting NLRP3 inflammasome activation through the Nrf2/TXNIP pathway; genetic deletion of ChemR23 in diabetic mice exacerbates cognitive impairment and oxidative stress, abolishing beneficial effects of agonists.","method":"ChemR23 KO mice, RvE1/chemerin-9 treatment, Nrf2/TXNIP western blot, NLRP3 inflammasome assays, cognitive behavioral tests","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO confirming receptor necessity, mechanistic pathway signaling, single lab","pmids":["36446229"],"is_preprint":false},{"year":2023,"finding":"RvE1/ChemR23 ameliorates angiotensin II-induced hypertension and vascular remodeling by activating AMPKα/Nrf2 signaling in VSMCs, inhibiting the canonical NF-κB/Ccl5 pathway to reduce macrophage and T-cell infiltration and suppressing VSMC phenotypic transformation and proliferation; knockdown of ChemR23 reverses these protective effects.","method":"AAV9-shRNA ChemR23 knockdown in mice, Ang II hypertension model, blood pressure measurement, aortic histology, AMPKα/Nrf2/NF-κB pathway western blot, immune cell quantification","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo knockdown plus mechanistic pathway analysis, single lab","pmids":["37800344"],"is_preprint":false},{"year":2024,"finding":"CMKLR1 controls lipid metabolism in clear cell renal cell carcinoma by enforcing suppression of adipose triglyceride lipase, regulating sterol regulatory element-binding protein 1c and CD36 scavenger receptor-mediated lipid uptake; genetic or pharmacological suppression of CMKLR1 induces apoptosis, ferroptosis, and autophagy, reducing ccRCC tumor growth in patient-derived xenografts.","method":"siRNA/shRNA knockdown, α-NETA pharmacological inhibition, lipidomic profiling, transcriptomic profiling, patient-derived xenograft models","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple receptor-specific genetic and pharmacological tools, comprehensive lipidomics, in vivo PDX validation","pmids":["38640229"],"is_preprint":false}],"current_model":"CMKLR1 (ChemR23) is a seven-transmembrane Gi/o-coupled GPCR that binds chemerin and resolvin E1 to signal through Gαi/o-mediated adenylyl cyclase inhibition, Ca2+ flux, RhoA/ROCK-SRF, PI3K/Akt, MAPK, CAMKK2/AMPK, and NF-κB pathways; GRK6 phosphorylation triggers β-arrestin 2 recruitment, receptor internalization and desensitization; expressed predominantly on plasmacytoid and myeloid dendritic cells, macrophages, and neutrophils, it directs DC trafficking to lymphoid organs and inflamed tissue, promotes macrophage efferocytosis and phagocytosis via Syk-dependent actin remodeling, resolves inflammation, regulates adipogenesis and thermogenesis via cAMP-PKA/IL-33, controls VSMC calcification and phenotypic switching, and suppresses tumor metastasis and PD-L1 through a CMKLR1-PTEN-Akt axis."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that CMKLR1 encodes an orphan GPCR with chemokine-receptor homology expressed in immune tissues provided the starting framework for identifying its ligands and immune functions.","evidence":"Molecular cloning, FISH mapping to 12q24.1, Northern blot in human tissues","pmids":["8976386"],"confidence":"Medium","gaps":["No ligand identified","No signaling pathway characterized","Functional role entirely unknown"]},{"year":2003,"claim":"Identification of chemerin (TIG2) as the endogenous ligand of CMKLR1 via reverse pharmacology deorphanized the receptor and enabled all subsequent mechanistic dissection.","evidence":"Reverse pharmacology screening of human hemofiltrate peptide libraries with receptor binding assay","pmids":["14675762"],"confidence":"High","gaps":["Active chemerin processing forms not yet defined","G protein coupling specificity unknown","Downstream signaling pathways uncharacterized"]},{"year":2005,"claim":"Demonstration that CMKLR1 mediates dendritic cell transendothelial migration toward chemerin established its primary physiological function as a chemoattractant receptor directing immune cell trafficking.","evidence":"Flow cytometry, transendothelial migration assay, immunohistochemical co-localization of ChemR23+ DCs with chemerin-expressing HEVs in lymphoid organs","pmids":["15728234"],"confidence":"High","gaps":["In vivo DC trafficking not yet confirmed with KO mice","Signaling intermediates between receptor activation and migration not defined"]},{"year":2007,"claim":"Direct radioligand binding showed resolvin E1 as a second endogenous ligand for CMKLR1, linking this receptor to the resolution of inflammation and omega-3 fatty acid biology.","evidence":"[³H]RvE1 binding (Kd ~48 nM), adenylate cyclase and NF-κB reporter assays, BLT1 KO mouse peritonitis","pmids":["17339491"],"confidence":"High","gaps":["Relative contributions of CMKLR1 vs. BLT1 to RvE1 effects not fully separated","RvE1-specific signaling downstream of CMKLR1 not distinguished from chemerin signaling"]},{"year":2008,"claim":"Using ChemR23-knockout mice, the processed C-terminal peptide chemerin15 was shown to suppress peritonitis entirely through CMKLR1, establishing that proteolytic activation of chemerin is essential for anti-inflammatory function.","evidence":"Zymosan peritonitis model, macrophage activation assays in ChemR23⁻/⁻ mice","pmids":["18391062"],"confidence":"High","gaps":["Specific proteases responsible for generating bioactive chemerin forms in vivo not identified","Downstream anti-inflammatory signaling pathway not delineated"]},{"year":2009,"claim":"Parallel studies using KO mice and differentiation assays established two distinct CMKLR1 functions: Gαi/o-dependent calcium flux and chemotaxis in immune cells, and a required role in adipogenesis via PPARγ-chemerin autocrine signaling.","evidence":"ChemR23 KO mouse calcium mobilization and chemotaxis, LPS lung inflammation model; RNAi of CMKLR1 in bone marrow stromal cell adipogenesis, PPARγ rescue","pmids":["19841182","19929432"],"confidence":"High","gaps":["Adipogenesis mechanism not linked to specific intracellular pathway","Relative importance of chemerin vs. RvE1 in metabolic contexts unknown"]},{"year":2010,"claim":"CMKLR1 was shown to enhance macrophage phagocytosis and efferocytosis through Syk kinase-dependent actin remodeling, providing a molecular mechanism for how this receptor promotes debris clearance during inflammation resolution.","evidence":"Phagocytosis and efferocytosis assays in ChemR23⁻/⁻ macrophages, Syk inhibitor, F-actin polymerization imaging","pmids":["20363975"],"confidence":"High","gaps":["Adaptor linking CMKLR1 to Syk activation not identified","Whether RvE1 uses the same Syk pathway not tested"]},{"year":2011,"claim":"ChemR23 KO mice revealed dual in vivo roles: recruiting pDCs for type I IFN-dependent antiviral defense in pneumonia, and regulating whole-body adiposity and glucose homeostasis.","evidence":"ChemR23 KO mice in pneumovirus infection (pDC adoptive transfer, chimeras) and metabolic phenotyping (glucose/insulin tolerance, body composition)","pmids":["22072972","22186410"],"confidence":"High","gaps":["Non-leukocytic anti-inflammatory function observed in chimeras not molecularly defined","How CMKLR1 deficiency impairs insulin secretion mechanistically unclear"]},{"year":2013,"claim":"Chemerin15 was found to inhibit neutrophil integrin activation and adhesion through CMKLR1, providing a mechanism for limiting neutrophil-mediated tissue damage; intravital microscopy confirmed neutrophil detachment from inflamed endothelium reduced myocardial infarction injury.","evidence":"Integrin activation assay, intravital microscopy, murine MI model with ChemR23 KO","pmids":["23999103"],"confidence":"High","gaps":["Signaling intermediate between CMKLR1 and integrin inactivation not identified","Whether chemerin15 or RvE1 is the physiological ligand in cardiac ischemia not determined"]},{"year":2016,"claim":"Comprehensive BRET-based profiling revealed CMKLR1 couples to all Gαi/o subtypes and recruits both β-arrestins; ERK1/2 activation requires Gαi/o plus β-arrestin 2 but not β-arrestin 1, establishing the receptor's full signaling repertoire.","evidence":"BRET G protein activation biosensors for Gαi1/2/3 and Gαoa/ob, β-arrestin recruitment assay, ERK phosphorylation","pmids":["27716822"],"confidence":"High","gaps":["No structural basis for G protein selectivity","β-arrestin-scaffolded signaling complexes not characterized"]},{"year":2018,"claim":"GRK6 was identified as the kinase that phosphorylates CMKLR1 for β-arrestin 2 recruitment and internalization; GRK6 and β-arrestin 2 KO macrophages showed enhanced migration and altered Akt/ERK signaling, establishing the desensitization mechanism.","evidence":"GRK6 and β-arrestin 2 KO mouse macrophages, receptor internalization, co-expression experiments, Akt/ERK western blot","pmids":["30576947"],"confidence":"High","gaps":["Specific phosphorylation sites on CMKLR1 C-tail not mapped","Other GRKs' contribution not excluded"]},{"year":2019,"claim":"Multiple studies established CMKLR1 as a vascular and neuroprotective receptor: RvE1/CMKLR1 inhibits VSMC calcification and phenotypic switching; chemerin/CMKLR1 suppresses hepatocellular carcinoma metastasis via physical interaction with PTEN stabilizing its expression and phosphatase activity; and CMKLR1 signals through CAMKK2/AMPK to reduce neuronal apoptosis.","evidence":"ChemR23 KO VSMCs and in vivo calcification; Co-IP of CMKLR1-PTEN, ubiquitination assay, xenograft; rat HIE model with pathway-specific inhibitors","pmids":["30597013","29717200","30718467"],"confidence":"High","gaps":["CMKLR1-PTEN interaction domain not mapped","Whether PTEN stabilization occurs in non-cancer cells not tested","CAMKK2 activation mechanism downstream of Gαi not resolved"]},{"year":2020,"claim":"CMKLR1 was shown to suppress PD-L1 expression through PTEN-Akt-mTOR signaling, establishing a tumor-immune evasion mechanism; separately, ChemR23 was confirmed as required for omega-3 PUFA-mediated protection against aortic valve calcification via genetic epistasis.","evidence":"CMKLR1 siRNA plus PI3K/AKT/mTOR inhibitors in tumor cells and xenografts; ChemR23 KO × Fat-1tg × Apoe⁻/⁻ triple-cross mice with echocardiography","pmids":["32605911","32506925"],"confidence":"High","gaps":["Whether CMKLR1-mediated PD-L1 suppression enhances anti-tumor immunity in immunocompetent models not shown","Specific RvE1-derived valve-protective signaling intermediates not identified"]},{"year":2021,"claim":"Adipocyte-specific CMKLR1 deletion revealed the receptor tonically suppresses beige adipocyte IL-33 production by dampening cAMP-PKA signaling, interrupting the feed-forward loop with type 2 innate immunity required for thermogenesis; an agonist anti-ChemR23 mAb separately confirmed that receptor activation directly promotes macrophage efferocytosis and resolves chronic colitis.","evidence":"Adipocyte-specific CMKLR1 KO mice under cold exposure and HFD, cAMP/PKA/IL-33 measurement; agonist mAb in peritonitis and colitis models with efferocytosis and neutrophil apoptosis readouts","pmids":["34330814","33811066"],"confidence":"High","gaps":["Whether cAMP-PKA suppression is Gαi-mediated or involves arrestin-dependent mechanism not distinguished","Agonist mAb signaling bias relative to chemerin not characterized"]},{"year":2024,"claim":"CMKLR1 was found to regulate lipid metabolism in clear cell renal cell carcinoma by suppressing adipose triglyceride lipase and modulating SREBP1c/CD36-mediated lipid uptake; CMKLR1 loss induced apoptosis, ferroptosis, and autophagy, revealing a metabolic dependency in lipid-laden tumors.","evidence":"siRNA/shRNA and α-NETA pharmacological inhibition, lipidomics, transcriptomics, patient-derived xenografts","pmids":["38640229"],"confidence":"High","gaps":["Direct signaling pathway from CMKLR1 to ATGL suppression not defined","Whether this lipid metabolic role applies beyond ccRCC not tested"]},{"year":null,"claim":"Key open questions include the structural basis of CMKLR1's dual ligand recognition (chemerin vs. RvE1), the phosphosite-level code for biased signaling, whether CMKLR1's PTEN-stabilizing and metabolic functions are linked through a common signaling branch, and the therapeutic potential of biased agonists versus antagonists across its immune, metabolic, and oncologic roles.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of CMKLR1","Biased agonism at CMKLR1 not systematically profiled","In vivo relevance of CMKLR1 as HIV/SIV coreceptor remains unclear"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,4,18,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[23,28,30]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,13,18]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[13,22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,8,15,18,22,26]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,5,6,9,11,13,17,31]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,12,30,35]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[26,27,35]}],"complexes":[],"partners":["RARRES2","ARRB2","GRK6","PTEN","SYK"],"other_free_text":[]},"mechanistic_narrative":"CMKLR1 (ChemR23/Chemerin1) is a Gi/o-coupled seven-transmembrane receptor that transduces signals from its primary ligands chemerin and resolvin E1 to coordinate immune cell trafficking, inflammation resolution, metabolic homeostasis, and vascular protection. Chemerin binding activates Gαi/o-mediated inhibition of adenylyl cyclase, Ca²⁺ mobilization, and downstream PI3K/Akt, ERK/MAPK, RhoA/ROCK-SRF, and CAMKK2/AMPK cascades, with GRK6-mediated phosphorylation triggering β-arrestin 2 recruitment, receptor internalization, and signal desensitization [PMID:18391062, PMID:27716822, PMID:30576947, PMID:26363224]. On plasmacytoid and myeloid dendritic cells, macrophages, and neutrophils, CMKLR1 directs chemotaxis toward chemerin-expressing tissues, promotes Syk-dependent macrophage efferocytosis and phagocytosis, suppresses neutrophil integrin activation to limit inflammatory tissue damage, and mediates RvE1-driven repolarization of M1 macrophages toward a resolution phenotype [PMID:15728234, PMID:20363975, PMID:23999103, PMID:25637017, PMID:29739755]. In non-immune contexts, CMKLR1 signaling regulates adipogenesis and cold-induced thermogenesis through cAMP-PKA/IL-33 suppression in adipocytes, controls vascular smooth muscle cell phenotypic switching and calcification, and constrains tumor progression by stabilizing PTEN to suppress Akt and PD-L1 expression [PMID:19929432, PMID:34330814, PMID:30597013, PMID:29717200, PMID:32605911]."},"prefetch_data":{"uniprot":{"accession":"Q99788","full_name":"Chemerin-like receptor 1","aliases":["Chemokine-like receptor 1","G-protein coupled receptor ChemR23","G-protein coupled receptor DEZ"],"length_aa":373,"mass_kda":42.3,"function":"Receptor for the chemoattractant adipokine chemerin/RARRES2 and for the omega-3 fatty acid derived molecule resolvin E1. Interaction with RARRES2 initiates activation of G proteins G(i)/G(o) and beta-arrestin pathways inducing cellular responses via second messenger pathways such as intracellular calcium mobilization, phosphorylation of MAP kinases MAPK1/MAPK3 (ERK1/2), TYRO3, MAPK14/P38MAPK and PI3K leading to multifunctional effects, like reduction of immune responses, enhancing of adipogenesis and angionesis (PubMed:27716822). Resolvin E1 down-regulates cytokine production in macrophages by reducing the activation of MAPK1/3 (ERK1/2) and NF-kappa-B. Positively regulates adipogenesis and adipocyte metabolism (Microbial infection) Acts as a coreceptor for several SIV strains (SIVMAC316, SIVMAC239, SIVMACL7E-FR and SIVSM62A), as well as a primary HIV-1 strain (92UG024-2)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q99788/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CMKLR1","classification":"Not Classified","n_dependent_lines":15,"n_total_lines":1208,"dependency_fraction":0.012417218543046357},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CMKLR1","total_profiled":1310},"omim":[{"mim_id":"608379","title":"CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2; CCRL2","url":"https://www.omim.org/entry/608379"},{"mim_id":"602351","title":"CHEMERIN CHEMOKINE-LIKE RECEPTOR 1; CMKLR1","url":"https://www.omim.org/entry/602351"},{"mim_id":"601973","title":"RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2","url":"https://www.omim.org/entry/601973"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":32.3}],"url":"https://www.proteinatlas.org/search/CMKLR1"},"hgnc":{"alias_symbol":["RVER1","ERV1","ChemR23"],"prev_symbol":[]},"alphafold":{"accession":"Q99788","domains":[{"cath_id":"1.20.1070.10","chopping":"36-195_212-248_256-321","consensus_level":"medium","plddt":91.4009,"start":36,"end":321}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99788","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99788-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99788-F1-predicted_aligned_error_v6.png","plddt_mean":79.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CMKLR1","jax_strain_url":"https://www.jax.org/strain/search?query=CMKLR1"},"sequence":{"accession":"Q99788","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99788.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99788/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99788"}},"corpus_meta":[{"pmid":"17339491","id":"PMC_17339491","title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17339491","citation_count":489,"is_preprint":false},{"pmid":"18391062","id":"PMC_18391062","title":"Synthetic chemerin-derived peptides suppress inflammation through ChemR23.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18391062","citation_count":309,"is_preprint":false},{"pmid":"20044979","id":"PMC_20044979","title":"Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20044979","citation_count":280,"is_preprint":false},{"pmid":"15728234","id":"PMC_15728234","title":"Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15728234","citation_count":235,"is_preprint":false},{"pmid":"19841182","id":"PMC_19841182","title":"Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19841182","citation_count":207,"is_preprint":false},{"pmid":"16185707","id":"PMC_16185707","title":"Erv1 mediates the Mia40-dependent protein import pathway and provides a functional link to the respiratory chain by shuttling electrons to cytochrome c.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16185707","citation_count":198,"is_preprint":false},{"pmid":"9603476","id":"PMC_9603476","title":"ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9603476","citation_count":198,"is_preprint":false},{"pmid":"14675762","id":"PMC_14675762","title":"Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/14675762","citation_count":167,"is_preprint":false},{"pmid":"20188670","id":"PMC_20188670","title":"Mitochondrial disulfide bond formation is driven by intersubunit electron transfer in Erv1 and proofread by glutathione.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20188670","citation_count":158,"is_preprint":false},{"pmid":"29279348","id":"PMC_29279348","title":"International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.","date":"2017","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/29279348","citation_count":148,"is_preprint":false},{"pmid":"27716822","id":"PMC_27716822","title":"Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27716822","citation_count":143,"is_preprint":false},{"pmid":"21056554","id":"PMC_21056554","title":"Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.","date":"2010","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21056554","citation_count":138,"is_preprint":false},{"pmid":"25637017","id":"PMC_25637017","title":"ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25637017","citation_count":137,"is_preprint":false},{"pmid":"19929432","id":"PMC_19929432","title":"Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.","date":"2010","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/19929432","citation_count":132,"is_preprint":false},{"pmid":"22186410","id":"PMC_22186410","title":"Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22186410","citation_count":132,"is_preprint":false},{"pmid":"25548799","id":"PMC_25548799","title":"Chemerin/chemR23 axis in inflammation onset and resolution.","date":"2014","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/25548799","citation_count":131,"is_preprint":false},{"pmid":"16181637","id":"PMC_16181637","title":"The essential mitochondrial protein Erv1 cooperates with Mia40 in biogenesis of intermembrane space proteins.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16181637","citation_count":130,"is_preprint":false},{"pmid":"36614339","id":"PMC_36614339","title":"Correction: Chen et al. The Chemerin/CMKLR1 Axis Is Involved in the Recruitment of Microglia to Aβ Deposition through p38 MAPK Pathway. Int. J. Mol. Sci. 2022, 23, 9041.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36614339","citation_count":129,"is_preprint":false},{"pmid":"10627538","id":"PMC_10627538","title":"An African swine fever virus ERV1-ALR homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine.","date":"2000","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/10627538","citation_count":126,"is_preprint":false},{"pmid":"11035794","id":"PMC_11035794","title":"A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11035794","citation_count":125,"is_preprint":false},{"pmid":"29739755","id":"PMC_29739755","title":"ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.","date":"2018","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/29739755","citation_count":118,"is_preprint":false},{"pmid":"21192818","id":"PMC_21192818","title":"Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157).","date":"2010","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21192818","citation_count":113,"is_preprint":false},{"pmid":"18179776","id":"PMC_18179776","title":"The Erv1-Mia40 disulfide relay system in the intermembrane space of mitochondria.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18179776","citation_count":95,"is_preprint":false},{"pmid":"20147447","id":"PMC_20147447","title":"Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20147447","citation_count":93,"is_preprint":false},{"pmid":"22072972","id":"PMC_22072972","title":"ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/22072972","citation_count":84,"is_preprint":false},{"pmid":"28149831","id":"PMC_28149831","title":"Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28149831","citation_count":75,"is_preprint":false},{"pmid":"32390873","id":"PMC_32390873","title":"Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32390873","citation_count":74,"is_preprint":false},{"pmid":"21346723","id":"PMC_21346723","title":"The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis.","date":"2011","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/21346723","citation_count":73,"is_preprint":false},{"pmid":"26363224","id":"PMC_26363224","title":"CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.","date":"2015","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26363224","citation_count":70,"is_preprint":false},{"pmid":"29090333","id":"PMC_29090333","title":"Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23.","date":"2017","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29090333","citation_count":68,"is_preprint":false},{"pmid":"7954891","id":"PMC_7954891","title":"ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae.","date":"1994","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7954891","citation_count":66,"is_preprint":false},{"pmid":"19477928","id":"PMC_19477928","title":"Reconstitution of the mia40-erv1 oxidative folding pathway for the small tim proteins.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19477928","citation_count":63,"is_preprint":false},{"pmid":"33811066","id":"PMC_33811066","title":"Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33811066","citation_count":62,"is_preprint":false},{"pmid":"24779513","id":"PMC_24779513","title":"Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?","date":"2014","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24779513","citation_count":62,"is_preprint":false},{"pmid":"10206950","id":"PMC_10206950","title":"Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10206950","citation_count":60,"is_preprint":false},{"pmid":"29717200","id":"PMC_29717200","title":"Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.","date":"2018","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29717200","citation_count":60,"is_preprint":false},{"pmid":"25437209","id":"PMC_25437209","title":"A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25437209","citation_count":60,"is_preprint":false},{"pmid":"32506925","id":"PMC_32506925","title":"Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis.","date":"2020","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/32506925","citation_count":59,"is_preprint":false},{"pmid":"8575761","id":"PMC_8575761","title":"A new human gene located in the PKD1 region of chromosome 16 is a functional homologue to ERV1 of yeast.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8575761","citation_count":59,"is_preprint":false},{"pmid":"20363975","id":"PMC_20363975","title":"Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20363975","citation_count":59,"is_preprint":false},{"pmid":"21430224","id":"PMC_21430224","title":"The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21430224","citation_count":56,"is_preprint":false},{"pmid":"32605911","id":"PMC_32605911","title":"Chemerin Reactivates PTEN and Suppresses PD-L1 in Tumor Cells via Modulation of a Novel CMKLR1-mediated Signaling Cascade.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32605911","citation_count":56,"is_preprint":false},{"pmid":"17336303","id":"PMC_17336303","title":"The sulfhydryl oxidase Erv1 is a substrate of the Mia40-dependent protein translocation pathway.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17336303","citation_count":55,"is_preprint":false},{"pmid":"30718467","id":"PMC_30718467","title":"Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30718467","citation_count":54,"is_preprint":false},{"pmid":"26864035","id":"PMC_26864035","title":"Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 Receptor.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26864035","citation_count":54,"is_preprint":false},{"pmid":"8976386","id":"PMC_8976386","title":"Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors.","date":"1996","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8976386","citation_count":53,"is_preprint":false},{"pmid":"25079809","id":"PMC_25079809","title":"The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide.","date":"2015","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/25079809","citation_count":47,"is_preprint":false},{"pmid":"36446229","id":"PMC_36446229","title":"ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36446229","citation_count":47,"is_preprint":false},{"pmid":"34330814","id":"PMC_34330814","title":"The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/IL-33/type 2 innate immunity circuit.","date":"2021","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34330814","citation_count":45,"is_preprint":false},{"pmid":"27092781","id":"PMC_27092781","title":"The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27092781","citation_count":45,"is_preprint":false},{"pmid":"22118966","id":"PMC_22118966","title":"Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.","date":"2011","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22118966","citation_count":45,"is_preprint":false},{"pmid":"30784180","id":"PMC_30784180","title":"Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30784180","citation_count":45,"is_preprint":false},{"pmid":"23999103","id":"PMC_23999103","title":"Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23.","date":"2013","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/23999103","citation_count":44,"is_preprint":false},{"pmid":"22918950","id":"PMC_22918950","title":"In vivo evidence for cooperation of Mia40 and Erv1 in the oxidation of mitochondrial proteins.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22918950","citation_count":44,"is_preprint":false},{"pmid":"23264646","id":"PMC_23264646","title":"Divergence of Erv1-associated mitochondrial import and export pathways in trypanosomes and anaerobic protists.","date":"2012","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/23264646","citation_count":42,"is_preprint":false},{"pmid":"29221117","id":"PMC_29221117","title":"Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29221117","citation_count":41,"is_preprint":false},{"pmid":"28993702","id":"PMC_28993702","title":"ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28993702","citation_count":37,"is_preprint":false},{"pmid":"30597013","id":"PMC_30597013","title":"The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification.","date":"2019","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/30597013","citation_count":36,"is_preprint":false},{"pmid":"30786742","id":"PMC_30786742","title":"Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30786742","citation_count":35,"is_preprint":false},{"pmid":"30426542","id":"PMC_30426542","title":"Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-κB signaling.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30426542","citation_count":34,"is_preprint":false},{"pmid":"30719206","id":"PMC_30719206","title":"Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30719206","citation_count":34,"is_preprint":false},{"pmid":"37932279","id":"PMC_37932279","title":"ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion by inhibiting NLRP3 inflammasome-induced neuronal pyroptosis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37932279","citation_count":33,"is_preprint":false},{"pmid":"37800344","id":"PMC_37800344","title":"Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice.","date":"2023","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/37800344","citation_count":33,"is_preprint":false},{"pmid":"28625137","id":"PMC_28625137","title":"Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer.","date":"2017","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/28625137","citation_count":32,"is_preprint":false},{"pmid":"20367271","id":"PMC_20367271","title":"The N-terminal shuttle domain of Erv1 determines the affinity for Mia40 and mediates electron transfer to the catalytic Erv1 core in yeast mitochondria.","date":"2010","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20367271","citation_count":32,"is_preprint":false},{"pmid":"29146976","id":"PMC_29146976","title":"Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29146976","citation_count":32,"is_preprint":false},{"pmid":"22768214","id":"PMC_22768214","title":"The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22768214","citation_count":32,"is_preprint":false},{"pmid":"34398343","id":"PMC_34398343","title":"Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBPɑ axis and inducing M1 macrophage polarization.","date":"2021","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34398343","citation_count":31,"is_preprint":false},{"pmid":"31399499","id":"PMC_31399499","title":"Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31399499","citation_count":31,"is_preprint":false},{"pmid":"30595125","id":"PMC_30595125","title":"Parental Dietary Protein Source and the Role of CMKLR1 in Determining the Severity of Dahl Salt-Sensitive Hypertension.","date":"2019","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/30595125","citation_count":30,"is_preprint":false},{"pmid":"28670396","id":"PMC_28670396","title":"Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism.","date":"2017","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/28670396","citation_count":30,"is_preprint":false},{"pmid":"31197872","id":"PMC_31197872","title":"Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.","date":"2019","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31197872","citation_count":30,"is_preprint":false},{"pmid":"32526705","id":"PMC_32526705","title":"Chemerin facilitates intervertebral disc degeneration via TLR4 and CMKLR1 and activation of NF-kB signaling pathway.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32526705","citation_count":30,"is_preprint":false},{"pmid":"26773141","id":"PMC_26773141","title":"Pro- and Anti-Inflammatory Role of ChemR23 Signaling in Pollutant-Induced Inflammatory Lung Responses.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26773141","citation_count":29,"is_preprint":false},{"pmid":"22350950","id":"PMC_22350950","title":"Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.","date":"2012","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22350950","citation_count":29,"is_preprint":false},{"pmid":"28814504","id":"PMC_28814504","title":"Osm1 facilitates the transfer of electrons from Erv1 to fumarate in the redox-regulated import pathway in the mitochondrial intermembrane space.","date":"2017","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28814504","citation_count":29,"is_preprint":false},{"pmid":"33144092","id":"PMC_33144092","title":"Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway.","date":"2020","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/33144092","citation_count":28,"is_preprint":false},{"pmid":"20663411","id":"PMC_20663411","title":"Cloning of porcine chemerin, ChemR23 and GPR1 and their involvement in regulation of lipogenesis.","date":"2010","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/20663411","citation_count":28,"is_preprint":false},{"pmid":"32630345","id":"PMC_32630345","title":"Chemerin Impairs In Vitro Testosterone Production, Sperm Motility, and Fertility in Chicken: Possible Involvement of Its Receptor CMKLR1.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32630345","citation_count":28,"is_preprint":false},{"pmid":"22296668","id":"PMC_22296668","title":"Targeting and maturation of Erv1/ALR in the mitochondrial intermembrane space.","date":"2012","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/22296668","citation_count":28,"is_preprint":false},{"pmid":"26893072","id":"PMC_26893072","title":"CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26893072","citation_count":28,"is_preprint":false},{"pmid":"30515096","id":"PMC_30515096","title":"Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30515096","citation_count":28,"is_preprint":false},{"pmid":"21542878","id":"PMC_21542878","title":"Chemerin/ChemR23 pathway: a system beyond chemokines.","date":"2011","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21542878","citation_count":27,"is_preprint":false},{"pmid":"35459783","id":"PMC_35459783","title":"Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35459783","citation_count":27,"is_preprint":false},{"pmid":"34461109","id":"PMC_34461109","title":"HOXA9-induced chemerin signals through CMKLR1/AMPK/TXNIP/NLRP3 pathway to induce pyroptosis of trophoblasts and aggravate preeclampsia.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34461109","citation_count":26,"is_preprint":false},{"pmid":"28326537","id":"PMC_28326537","title":"Gax suppresses chemerin/CMKLR1-induced preadipocyte biofunctions through the inhibition of Akt/mTOR and ERK signaling pathways.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28326537","citation_count":26,"is_preprint":false},{"pmid":"22796467","id":"PMC_22796467","title":"Chronic mild restraint stress rats decreased CMKLR1 expression in distinct brain region.","date":"2012","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/22796467","citation_count":26,"is_preprint":false},{"pmid":"35317838","id":"PMC_35317838","title":"Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction.","date":"2022","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35317838","citation_count":25,"is_preprint":false},{"pmid":"26972253","id":"PMC_26972253","title":"CMKLR1 deficiency influences glucose tolerance and thermogenesis in mice on high fat diet.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26972253","citation_count":24,"is_preprint":false},{"pmid":"25699203","id":"PMC_25699203","title":"Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes.","date":"2015","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/25699203","citation_count":24,"is_preprint":false},{"pmid":"22910915","id":"PMC_22910915","title":"Structure of yeast sulfhydryl oxidase erv1 reveals electron transfer of the disulfide relay system in the mitochondrial intermembrane space.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22910915","citation_count":24,"is_preprint":false},{"pmid":"26265756","id":"PMC_26265756","title":"Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitis.","date":"2015","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/26265756","citation_count":24,"is_preprint":false},{"pmid":"30576947","id":"PMC_30576947","title":"Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages.","date":"2018","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30576947","citation_count":24,"is_preprint":false},{"pmid":"29117860","id":"PMC_29117860","title":"Erv1 of Arabidopsis thaliana can directly oxidize mitochondrial intermembrane space proteins in the absence of redox-active Mia40.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117860","citation_count":24,"is_preprint":false},{"pmid":"38640229","id":"PMC_38640229","title":"GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38640229","citation_count":23,"is_preprint":false},{"pmid":"30873215","id":"PMC_30873215","title":"Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARγ.","date":"2019","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30873215","citation_count":23,"is_preprint":false},{"pmid":"31588246","id":"PMC_31588246","title":"CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31588246","citation_count":23,"is_preprint":false},{"pmid":"25049696","id":"PMC_25049696","title":"The Regulation of Chemerin and CMKLR1 Genes Expression by TNF-α, Adiponectin, and Chemerin Analog in Bovine Differentiated Adipocytes.","date":"2012","source":"Asian-Australasian journal of animal sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25049696","citation_count":23,"is_preprint":false},{"pmid":"37201735","id":"PMC_37201735","title":"Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis.","date":"2023","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/37201735","citation_count":22,"is_preprint":false},{"pmid":"35711300","id":"PMC_35711300","title":"The Chemerin-CMKLR1 Axis is Functionally important for Central Regulation of Energy Homeostasis.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35711300","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51900,"output_tokens":8314,"usd":0.140205},"stage2":{"model":"claude-opus-4-6","input_tokens":12306,"output_tokens":4059,"usd":0.244507},"total_usd":0.384712,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"CMKLR1 encodes a seven-transmembrane G protein-linked receptor with sequence homology to chemokine receptors, expressed in hematopoietic and immune tissues; chromosomal localization to 12q24.1 established by FISH.\",\n      \"method\": \"Molecular cloning, FISH chromosomal mapping, Northern blot expression profiling\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — original cloning paper with structural characterization, single lab\",\n      \"pmids\": [\"8976386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ChemR23 (CMKLR1) is expressed in monocyte-derived dendritic cells and macrophages and functions as a coreceptor for SIV and some primary HIV-1 strains in cell fusion assays.\",\n      \"method\": \"RT-PCR expression profiling, cell fusion coreceptor assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional fusion assay, single lab, replicated across multiple viral strains\",\n      \"pmids\": [\"9603476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TIG2/chemerin (residues 21–154 of the prepropeptide) was identified as the natural ligand of ChemR23 (CMKLR1) via reverse pharmacology screening of peptide libraries from human hemofiltrate.\",\n      \"method\": \"Reverse pharmacology peptide library screening, receptor binding assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical identification of endogenous ligand using receptor binding\",\n      \"pmids\": [\"14675762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ChemR23 (CMKLR1) is expressed and functional in plasmacytoid and myeloid dendritic cells; recombinant chemerin induces transmigration of these DCs across endothelial monolayers, and ChemR23+ DCs localize near chemerin-expressing high endothelial venules in lymphoid organs.\",\n      \"method\": \"Flow cytometry, transendothelial migration assay, immunohistochemistry, co-localization\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, functional migration assay, in vivo localization\",\n      \"pmids\": [\"15728234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RvE1 binds specifically to ChemR23 (CMKLR1) on human PMNs (Kd ~48 nM); RvE1 also binds recombinant BLT1 (Kd 45 nM) and acts as a partial agonist at BLT1, inhibiting adenylate cyclase and NF-κB activation, while its anti-inflammatory actions at higher doses involve ChemR23-mediated counterregulatory mechanisms.\",\n      \"method\": \"[3H]RvE1 radioligand binding assay, adenylate cyclase assay, NF-κB reporter assay, BLT1 knockout mouse peritonitis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct radioligand binding with Kd determination, multiple functional assays, in vivo KO validation\",\n      \"pmids\": [\"17339491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Chemerin requires proteolytic processing of its C-terminus for anti-inflammatory activity; the C-terminal peptide chemerin15 (A140–A154) suppresses macrophage activation and peritonitis at picomolar concentrations in a ChemR23-dependent manner, as shown by complete loss of activity in ChemR23−/− mice.\",\n      \"method\": \"In vitro macrophage activation assay, zymosan peritonitis model, ChemR23 knockout mice\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro and in vivo with KO confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"18391062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mouse ChemR23 mediates chemerin-induced calcium mobilization and chemotaxis in dendritic cells and macrophages; these responses are abrogated in ChemR23 knockout mice. Chemerin reduces neutrophil infiltration and inflammatory cytokine release in LPS-induced lung inflammation in a ChemR23-dependent manner.\",\n      \"method\": \"Calcium mobilization assay, chemotaxis assay, ChemR23 KO mice, LPS-induced lung inflammation model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with KO confirmation, in vivo and in vitro\",\n      \"pmids\": [\"19841182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Chemerin/CMKLR1 signaling is required for adipocyte differentiation of bone marrow stromal cells; RNAi knockdown of chemerin or CMKLR1 abrogates adipogenesis and clonal expansion, while increasing osteoblast marker expression and mineralization; PPARγ-induced chemerin expression partially rescues adipogenesis.\",\n      \"method\": \"RNAi knockdown, differentiation assays, PPARγ overexpression rescue experiment\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific cellular phenotype, rescue experiment, multiple cell types\",\n      \"pmids\": [\"19929432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Chemerin activates ChemR23 in human endothelial cells, inducing angiogenesis through activation of PI3K/Akt and MAPK signaling pathways, and dose-dependently increases MMP-2 and MMP-9 gelatinolytic activity.\",\n      \"method\": \"In vitro angiogenesis assays (tube formation, migration), phosphorylation western blot, zymography\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional assays with signaling, single lab, no ChemR23 KO confirmation\",\n      \"pmids\": [\"20044979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Chemerin15 enhances macrophage phagocytosis of microbial particles and efferocytosis of apoptotic cells via ChemR23, associated with increased actin polymerization and F-actin localization to the phagocytic cup; these effects require Syk kinase activity and are absent in ChemR23−/− macrophages.\",\n      \"method\": \"Phagocytosis assays, ChemR23 KO macrophages, Syk inhibitor, actin polymerization assay, in vivo peritonitis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO confirmation, pharmacological inhibition, in vitro and in vivo, multiple orthogonal readouts\",\n      \"pmids\": [\"20363975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Chemerin binding to ChemR23 in human articular chondrocytes induces phosphorylation of ERK1/2 and Akt, and promotes secretion of pro-inflammatory cytokines (IL-6, IL-8, TNF-α, IL-1β) and matrix metalloproteases (MMP-1, -2, -3, -8, -13).\",\n      \"method\": \"Phosphorylation western blot, ELISA cytokine quantification, cell stimulation assay\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional signaling assays, single lab, no receptor KO confirmation\",\n      \"pmids\": [\"21192818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ChemR23 knockout mice show increased neutrophilic infiltration, delayed viral clearance, and higher mortality in pneumonia virus of mice infection; ChemR23 recruits plasmacytoid DCs to promote type I interferon production and adaptive immune responses, while ChemR23 on non-leukocytic cells provides a separate anti-inflammatory function.\",\n      \"method\": \"ChemR23 KO mice, depletion/adoptive transfer of pDCs, chimeric mice, lung function measurement, interferon quantification\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic tools, adoptive transfer epistasis, in vivo mechanistic dissection\",\n      \"pmids\": [\"22072972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CMKLR1-deficient mice show reduced adiposity, lower food consumption, decreased adipose/hepatic inflammation, and glucose intolerance with impaired glucose-stimulated insulin secretion and reduced skeletal muscle/adipose tissue glucose uptake, demonstrating CMKLR1's role in adipose development, inflammation, and glucose homeostasis.\",\n      \"method\": \"CMKLR1 KO mouse model, body composition analysis, glucose/insulin tolerance tests, immune cell profiling, glucose uptake assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive KO phenotyping with multiple orthogonal readouts\",\n      \"pmids\": [\"22186410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ChemR23 is expressed in neutrophil granules and is upregulated upon neutrophil activation; chemerin15 inhibits integrin activation and clustering via ChemR23, reducing neutrophil adhesion and chemotaxis in vitro and inducing detachment of adherent neutrophils from inflamed endothelium, reducing heart damage in a murine myocardial infarction model.\",\n      \"method\": \"Flow cytometry, integrin activation assay, intravital microscopy, murine MI model, ChemR23 KO\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic in vitro plus in vivo with KO, multiple assays\",\n      \"pmids\": [\"23999103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The small molecule α-NETA inhibits chemerin-stimulated β-arrestin2 association with CMKLR1 and blocks chemerin-triggered CMKLR1+ cell migration, acting as a CMKLR1 antagonist; α-NETA delays EAE onset and reduces CNS mononuclear cell infiltrates.\",\n      \"method\": \"β-arrestin2 recruitment assay, chemotaxis assay, EAE mouse model (active immunization and adoptive transfer)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct receptor signaling assay plus in vivo pharmacological validation\",\n      \"pmids\": [\"25437209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Chemerin signals through CMKLR1 via the RhoA/ROCK pathway to activate the transcriptional regulator SRF; RhoA, ROCK, p38, and Gαi/o signaling are all required for chemerin-mediated chemotaxis; GPR1 is confirmed as a functional chemerin receptor with similar but distinct signaling properties.\",\n      \"method\": \"Luciferase reporter assays, pathway-specific inhibitors, chemotaxis assay, CMKLR1/GPR1 transfection\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and reporter assays, single lab\",\n      \"pmids\": [\"26363224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Aβ42 binds specifically to CMKLR1 in stably transfected RBL cells; Aβ42 induces CMKLR1-dependent cell migration through ERK1/2, PKA, and Akt pathways (but not Ca2+ mobilization), and CMKLR1 mediates internalization of the Aβ42-CMKLR1 complex in primary glial cells.\",\n      \"method\": \"Radioligand-like specific binding in transfected cells, migration assays, signaling pathway inhibitors, internalization assay\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay plus functional KD/KO comparison, single lab\",\n      \"pmids\": [\"25079809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ChemR23 expression is regulated at the transcriptional level; M1 macrophages (stimulated by LPS or IFN-γ) upregulate ChemR23 from promoter P3, are chemotactic to chemerin, and are repolarized toward a resolution phenotype by RvE1 through ChemR23, increasing IL-10 and phagocytosis; M2 macrophages do not express surface ChemR23.\",\n      \"method\": \"5' RACE, promoter analysis, FACS, chemotaxis assay, RvE1 stimulation, phagocytosis assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, mechanistic transcriptional and functional characterization\",\n      \"pmids\": [\"25637017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Chemerin binding to CMKLR1 activates all three Gαi subtypes (Gαi1, Gαi2, Gαi3) and both Gαo isoforms (Gαoa, Gαob), recruits β-arrestin1 and β-arrestin2, and induces receptor internalization and ERK1/2 phosphorylation; ERK1/2 phosphorylation requires both Gαi/o and β-arrestin2 activation but not β-arrestin1.\",\n      \"method\": \"BRET-based G protein activation biosensors, β-arrestin recruitment assay, receptor internalization assay, ERK phosphorylation western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — BRET biosensors with multiple G protein subtypes, multiple orthogonal signaling assays\",\n      \"pmids\": [\"27716822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The IUPHAR nomenclature review confirmed that chemerin activates CMKLR1 (Chemerin1) via Gi/o coupling causing inhibition of adenylyl cyclase and increased Ca2+ flux; human chemerin21-157 is the most active form; CCX832 selectively blocks CMKLR1; resolvin E1 also activates CMKLR1.\",\n      \"method\": \"Pharmacological review integrating radioligand binding, cAMP, Ca2+ assays from multiple labs\",\n      \"journal\": \"Pharmacological reviews\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — authoritative review synthesizing multiple independent biochemical measurements\",\n      \"pmids\": [\"29279348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Targeted deletion of ERV1/ChemR23 in hyperlipidemic mice increases oxidized LDL uptake, reduces phagocytosis, and enlarges atherosclerotic plaques; resolvin E1-mediated effects on oxLDL uptake and phagocytosis in macrophages are dependent on ERV1/ChemR23 signaling.\",\n      \"method\": \"Erv1/ChemR23 KO × Apoe−/− mice, atherosclerosis histology, macrophage phagocytosis/oxLDL uptake assays, lipidomics\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent hyperlipidemic mouse models, direct mechanistic assays in macrophages\",\n      \"pmids\": [\"29739755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Chemerin activates CMKLR1 in oesophageal squamous cancer cells, increasing MMP-1, MMP-2, and MMP-3 abundance and activity through protein kinase C and p44/42 MAPK pathways, promoting cancer cell invasion; the ChemR23 antagonist CCX832 inhibits this invasion.\",\n      \"method\": \"Boyden chamber invasion assays, organotypic assays, siRNA, immunoneutralisation, CCX832 antagonist, western blot/enzyme assay for MMPs\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods and receptor specificity confirmed with antagonist and siRNA, single lab\",\n      \"pmids\": [\"27092781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Chemerin-activated CMKLR1 signaling in inflammatory macrophages is regulated by GRK6 phosphorylation and β-arrestin 2 recruitment; GRK6- and β-arrestin 2-deficient macrophages show decreased CMKLR1 internalization following chemerin stimulation, increased migration toward chemerin, and altered AKT and ERK signaling.\",\n      \"method\": \"GRK6 and β-arrestin 2 KO mouse macrophages, receptor internalization assay, co-expression of GRK6 with CMKLR1, chemotaxis assay, AKT/ERK western blot\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two KO models, direct internalization assay, mechanistic signaling dissection\",\n      \"pmids\": [\"30576947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1 by upregulating PTEN expression and phosphatase activity via interference with PTEN-CMKLR1 interaction, reducing PTEN ubiquitination and decreasing p-Akt (Ser473); CMKLR1 knockdown abolishes chemerin-induced PTEN/Akt modulation.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, phosphatase activity assay, ubiquitination assay, in vivo xenograft\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP for physical interaction, biochemical phosphatase assay, in vivo rescue, multiple methods\",\n      \"pmids\": [\"29717200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ChemR23 deletion in smooth muscle cells prevents phenotypic switching to a synthetic/osteoblastic state; ChemR23-deficient VSMCs are resistant to phosphate-induced calcification; resolvin E1 inhibits VSMC calcification through ChemR23; ChemR23-deficient mice are protected against vitamin D3-induced vascular calcification.\",\n      \"method\": \"ChemR23 KO mouse VSMCs, in vitro calcification assay, in vivo calcification model, Fat-1 transgene epistasis\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO, in vitro and in vivo, ligand rescue, multi-model validation\",\n      \"pmids\": [\"30597013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ChemR23-deficient pDCs exhibit reduced migratory capacity and decreased CCR7 expression; adoptive transfer of WT vs. ChemR23 KO pDCs into Apoe−/− mice shows reduced accumulation of ChemR23-deficient pDCs in atherosclerotic lesions; hematopoietic ChemR23 deficiency increases M2 macrophage proportion and cholesterol efflux in atherosclerotic plaques.\",\n      \"method\": \"ChemR23 KO knockin eGFP mice, adoptive pDC transfer, bone marrow chimeras, atherosclerosis histology, cholesterol efflux assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — adoptive transfer epistasis, multiple genetic models, mechanistic cell assays\",\n      \"pmids\": [\"30786742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Chemerin reduces neuronal apoptosis after neonatal hypoxic-ischemic encephalopathy via ChemR23/CAMKK2/AMPK signaling; specific inhibition of ChemR23, CAMKK2, or AMPK abolishes the anti-apoptotic effects of recombinant chemerin.\",\n      \"method\": \"Rat HIE model, intranasal chemerin administration, specific inhibitors, western blot for phospho-CAMKK2/AMPK, TUNEL/Fluoro-Jade staining\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo with pharmacological pathway inhibition at each step, single lab\",\n      \"pmids\": [\"30718467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Chemerin/CMKLR1 axis promotes inflammation and pyroptosis in diabetic cardiomyopathy through NLRP3 inflammasome activation; CMKLR1 siRNA knockdown in vivo attenuates NLRP3, activated caspase-1, and IL-1β; in vitro, silencing either CMKLR1 or NLRP3 suppresses pyroptosis.\",\n      \"method\": \"siRNA knockdown in vivo and in vitro, NLRP3 KD double knockdown, LDH release, caspase-1 western blot, EthD-III staining\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via double knockdown, multiple functional readouts, single lab\",\n      \"pmids\": [\"32390873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Exogenous chemerin exposure upregulates PTEN expression/activity and suppresses PD-L1 expression in human prostate and sarcoma tumor lines through CMKLR1; CMKLR1 knockdown abolishes these effects; signaling proceeds through PI3K/AKT/mTOR pathway; forced chemerin expression in DU145 xenografts suppresses tumor growth with increased PTEN and decreased PD-L1 in vivo.\",\n      \"method\": \"siRNA knockdown, specific PI3K/AKT/mTOR inhibitors, western blot, in vivo xenograft, T-cell cytotoxicity assay\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor KD to establish necessity, in vitro signaling + in vivo validation, multiple cell lines\",\n      \"pmids\": [\"32605911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Abrogation of ChemR23 in Apoe−/− Fat-1tg mice abolishes the protective effects of endogenous omega-3 fatty acids on aortic valve calcification; resolvin E1 acts as a calcification inhibitor and its receptor ChemR23 is required for n-3 PUFA-mediated valve protection.\",\n      \"method\": \"ChemR23 KO × Fat-1tg × Apoe−/− mouse model, valvular lipidomics, echocardiography, histology\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with triple-cross model, multiple functional readouts\",\n      \"pmids\": [\"32506925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The chemerin-CMKLR1 axis in adipocytes suppresses beige adipocyte-derived IL-33 by dampening cAMP-PKA signaling, thereby interrupting the feed-forward circuit between beige adipocytes and type 2 innate immunity required for cold-induced thermogenesis; adipocyte-specific CMKLR1 deletion enhances thermogenesis and protects against diet-induced obesity.\",\n      \"method\": \"Adipocyte-specific CMKLR1 KO mice, cold exposure, cAMP/PKA signaling assays, IL-33 quantification, innate immune cell profiling, diet-induced obesity model\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO, mechanistic signaling pathway delineation, multiple in vivo readouts\",\n      \"pmids\": [\"34330814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"An agonist anti-ChemR23 monoclonal antibody that induces receptor signaling promotes macrophage efferocytosis and reduces neutrophil apoptosis at the site of inflammation; it accelerates resolution of acute inflammation and triggers resolution in chronic colitis models.\",\n      \"method\": \"Agonist mAb characterization, macrophage efferocytosis assay, neutrophil apoptosis assay, acute peritonitis model, chronic colitis mouse model\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — agonist antibody with defined mechanism, multiple in vitro and in vivo models\",\n      \"pmids\": [\"33811066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Chemerin enhances mesenchymal features of glioblastoma via CMKLR1 by suppressing ubiquitin-proteasomal degradation of CMKLR1, thereby enhancing NF-κB pathway activation; chemerin promotes TAM recruitment and M2 polarization via CMKLR1/NF-κB axis, which further drives GBM mesenchymal phenotype.\",\n      \"method\": \"CMKLR1 ubiquitination/degradation assay, NF-κB reporter assay, TAM co-culture, GBM xenograft, α-NETA pharmacological blockade\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway with ubiquitination assay, in vivo validation, single lab\",\n      \"pmids\": [\"35459783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ChemR23 agonists RvE1 and chemerin-9 ameliorate diabetes-associated cognitive impairment by inhibiting NLRP3 inflammasome activation through the Nrf2/TXNIP pathway; genetic deletion of ChemR23 in diabetic mice exacerbates cognitive impairment and oxidative stress, abolishing beneficial effects of agonists.\",\n      \"method\": \"ChemR23 KO mice, RvE1/chemerin-9 treatment, Nrf2/TXNIP western blot, NLRP3 inflammasome assays, cognitive behavioral tests\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO confirming receptor necessity, mechanistic pathway signaling, single lab\",\n      \"pmids\": [\"36446229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RvE1/ChemR23 ameliorates angiotensin II-induced hypertension and vascular remodeling by activating AMPKα/Nrf2 signaling in VSMCs, inhibiting the canonical NF-κB/Ccl5 pathway to reduce macrophage and T-cell infiltration and suppressing VSMC phenotypic transformation and proliferation; knockdown of ChemR23 reverses these protective effects.\",\n      \"method\": \"AAV9-shRNA ChemR23 knockdown in mice, Ang II hypertension model, blood pressure measurement, aortic histology, AMPKα/Nrf2/NF-κB pathway western blot, immune cell quantification\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockdown plus mechanistic pathway analysis, single lab\",\n      \"pmids\": [\"37800344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CMKLR1 controls lipid metabolism in clear cell renal cell carcinoma by enforcing suppression of adipose triglyceride lipase, regulating sterol regulatory element-binding protein 1c and CD36 scavenger receptor-mediated lipid uptake; genetic or pharmacological suppression of CMKLR1 induces apoptosis, ferroptosis, and autophagy, reducing ccRCC tumor growth in patient-derived xenografts.\",\n      \"method\": \"siRNA/shRNA knockdown, α-NETA pharmacological inhibition, lipidomic profiling, transcriptomic profiling, patient-derived xenograft models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple receptor-specific genetic and pharmacological tools, comprehensive lipidomics, in vivo PDX validation\",\n      \"pmids\": [\"38640229\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CMKLR1 (ChemR23) is a seven-transmembrane Gi/o-coupled GPCR that binds chemerin and resolvin E1 to signal through Gαi/o-mediated adenylyl cyclase inhibition, Ca2+ flux, RhoA/ROCK-SRF, PI3K/Akt, MAPK, CAMKK2/AMPK, and NF-κB pathways; GRK6 phosphorylation triggers β-arrestin 2 recruitment, receptor internalization and desensitization; expressed predominantly on plasmacytoid and myeloid dendritic cells, macrophages, and neutrophils, it directs DC trafficking to lymphoid organs and inflamed tissue, promotes macrophage efferocytosis and phagocytosis via Syk-dependent actin remodeling, resolves inflammation, regulates adipogenesis and thermogenesis via cAMP-PKA/IL-33, controls VSMC calcification and phenotypic switching, and suppresses tumor metastasis and PD-L1 through a CMKLR1-PTEN-Akt axis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CMKLR1 (ChemR23/Chemerin1) is a Gi/o-coupled seven-transmembrane receptor that transduces signals from its primary ligands chemerin and resolvin E1 to coordinate immune cell trafficking, inflammation resolution, metabolic homeostasis, and vascular protection. Chemerin binding activates Gαi/o-mediated inhibition of adenylyl cyclase, Ca²⁺ mobilization, and downstream PI3K/Akt, ERK/MAPK, RhoA/ROCK-SRF, and CAMKK2/AMPK cascades, with GRK6-mediated phosphorylation triggering β-arrestin 2 recruitment, receptor internalization, and signal desensitization [PMID:18391062, PMID:27716822, PMID:30576947, PMID:26363224]. On plasmacytoid and myeloid dendritic cells, macrophages, and neutrophils, CMKLR1 directs chemotaxis toward chemerin-expressing tissues, promotes Syk-dependent macrophage efferocytosis and phagocytosis, suppresses neutrophil integrin activation to limit inflammatory tissue damage, and mediates RvE1-driven repolarization of M1 macrophages toward a resolution phenotype [PMID:15728234, PMID:20363975, PMID:23999103, PMID:25637017, PMID:29739755]. In non-immune contexts, CMKLR1 signaling regulates adipogenesis and cold-induced thermogenesis through cAMP-PKA/IL-33 suppression in adipocytes, controls vascular smooth muscle cell phenotypic switching and calcification, and constrains tumor progression by stabilizing PTEN to suppress Akt and PD-L1 expression [PMID:19929432, PMID:34330814, PMID:30597013, PMID:29717200, PMID:32605911].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that CMKLR1 encodes an orphan GPCR with chemokine-receptor homology expressed in immune tissues provided the starting framework for identifying its ligands and immune functions.\",\n      \"evidence\": \"Molecular cloning, FISH mapping to 12q24.1, Northern blot in human tissues\",\n      \"pmids\": [\"8976386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ligand identified\", \"No signaling pathway characterized\", \"Functional role entirely unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of chemerin (TIG2) as the endogenous ligand of CMKLR1 via reverse pharmacology deorphanized the receptor and enabled all subsequent mechanistic dissection.\",\n      \"evidence\": \"Reverse pharmacology screening of human hemofiltrate peptide libraries with receptor binding assay\",\n      \"pmids\": [\"14675762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active chemerin processing forms not yet defined\", \"G protein coupling specificity unknown\", \"Downstream signaling pathways uncharacterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that CMKLR1 mediates dendritic cell transendothelial migration toward chemerin established its primary physiological function as a chemoattractant receptor directing immune cell trafficking.\",\n      \"evidence\": \"Flow cytometry, transendothelial migration assay, immunohistochemical co-localization of ChemR23+ DCs with chemerin-expressing HEVs in lymphoid organs\",\n      \"pmids\": [\"15728234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo DC trafficking not yet confirmed with KO mice\", \"Signaling intermediates between receptor activation and migration not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Direct radioligand binding showed resolvin E1 as a second endogenous ligand for CMKLR1, linking this receptor to the resolution of inflammation and omega-3 fatty acid biology.\",\n      \"evidence\": \"[³H]RvE1 binding (Kd ~48 nM), adenylate cyclase and NF-κB reporter assays, BLT1 KO mouse peritonitis\",\n      \"pmids\": [\"17339491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of CMKLR1 vs. BLT1 to RvE1 effects not fully separated\", \"RvE1-specific signaling downstream of CMKLR1 not distinguished from chemerin signaling\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Using ChemR23-knockout mice, the processed C-terminal peptide chemerin15 was shown to suppress peritonitis entirely through CMKLR1, establishing that proteolytic activation of chemerin is essential for anti-inflammatory function.\",\n      \"evidence\": \"Zymosan peritonitis model, macrophage activation assays in ChemR23⁻/⁻ mice\",\n      \"pmids\": [\"18391062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific proteases responsible for generating bioactive chemerin forms in vivo not identified\", \"Downstream anti-inflammatory signaling pathway not delineated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Parallel studies using KO mice and differentiation assays established two distinct CMKLR1 functions: Gαi/o-dependent calcium flux and chemotaxis in immune cells, and a required role in adipogenesis via PPARγ-chemerin autocrine signaling.\",\n      \"evidence\": \"ChemR23 KO mouse calcium mobilization and chemotaxis, LPS lung inflammation model; RNAi of CMKLR1 in bone marrow stromal cell adipogenesis, PPARγ rescue\",\n      \"pmids\": [\"19841182\", \"19929432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adipogenesis mechanism not linked to specific intracellular pathway\", \"Relative importance of chemerin vs. RvE1 in metabolic contexts unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"CMKLR1 was shown to enhance macrophage phagocytosis and efferocytosis through Syk kinase-dependent actin remodeling, providing a molecular mechanism for how this receptor promotes debris clearance during inflammation resolution.\",\n      \"evidence\": \"Phagocytosis and efferocytosis assays in ChemR23⁻/⁻ macrophages, Syk inhibitor, F-actin polymerization imaging\",\n      \"pmids\": [\"20363975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adaptor linking CMKLR1 to Syk activation not identified\", \"Whether RvE1 uses the same Syk pathway not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"ChemR23 KO mice revealed dual in vivo roles: recruiting pDCs for type I IFN-dependent antiviral defense in pneumonia, and regulating whole-body adiposity and glucose homeostasis.\",\n      \"evidence\": \"ChemR23 KO mice in pneumovirus infection (pDC adoptive transfer, chimeras) and metabolic phenotyping (glucose/insulin tolerance, body composition)\",\n      \"pmids\": [\"22072972\", \"22186410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-leukocytic anti-inflammatory function observed in chimeras not molecularly defined\", \"How CMKLR1 deficiency impairs insulin secretion mechanistically unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Chemerin15 was found to inhibit neutrophil integrin activation and adhesion through CMKLR1, providing a mechanism for limiting neutrophil-mediated tissue damage; intravital microscopy confirmed neutrophil detachment from inflamed endothelium reduced myocardial infarction injury.\",\n      \"evidence\": \"Integrin activation assay, intravital microscopy, murine MI model with ChemR23 KO\",\n      \"pmids\": [\"23999103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling intermediate between CMKLR1 and integrin inactivation not identified\", \"Whether chemerin15 or RvE1 is the physiological ligand in cardiac ischemia not determined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Comprehensive BRET-based profiling revealed CMKLR1 couples to all Gαi/o subtypes and recruits both β-arrestins; ERK1/2 activation requires Gαi/o plus β-arrestin 2 but not β-arrestin 1, establishing the receptor's full signaling repertoire.\",\n      \"evidence\": \"BRET G protein activation biosensors for Gαi1/2/3 and Gαoa/ob, β-arrestin recruitment assay, ERK phosphorylation\",\n      \"pmids\": [\"27716822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for G protein selectivity\", \"β-arrestin-scaffolded signaling complexes not characterized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"GRK6 was identified as the kinase that phosphorylates CMKLR1 for β-arrestin 2 recruitment and internalization; GRK6 and β-arrestin 2 KO macrophages showed enhanced migration and altered Akt/ERK signaling, establishing the desensitization mechanism.\",\n      \"evidence\": \"GRK6 and β-arrestin 2 KO mouse macrophages, receptor internalization, co-expression experiments, Akt/ERK western blot\",\n      \"pmids\": [\"30576947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation sites on CMKLR1 C-tail not mapped\", \"Other GRKs' contribution not excluded\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Multiple studies established CMKLR1 as a vascular and neuroprotective receptor: RvE1/CMKLR1 inhibits VSMC calcification and phenotypic switching; chemerin/CMKLR1 suppresses hepatocellular carcinoma metastasis via physical interaction with PTEN stabilizing its expression and phosphatase activity; and CMKLR1 signals through CAMKK2/AMPK to reduce neuronal apoptosis.\",\n      \"evidence\": \"ChemR23 KO VSMCs and in vivo calcification; Co-IP of CMKLR1-PTEN, ubiquitination assay, xenograft; rat HIE model with pathway-specific inhibitors\",\n      \"pmids\": [\"30597013\", \"29717200\", \"30718467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CMKLR1-PTEN interaction domain not mapped\", \"Whether PTEN stabilization occurs in non-cancer cells not tested\", \"CAMKK2 activation mechanism downstream of Gαi not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CMKLR1 was shown to suppress PD-L1 expression through PTEN-Akt-mTOR signaling, establishing a tumor-immune evasion mechanism; separately, ChemR23 was confirmed as required for omega-3 PUFA-mediated protection against aortic valve calcification via genetic epistasis.\",\n      \"evidence\": \"CMKLR1 siRNA plus PI3K/AKT/mTOR inhibitors in tumor cells and xenografts; ChemR23 KO × Fat-1tg × Apoe⁻/⁻ triple-cross mice with echocardiography\",\n      \"pmids\": [\"32605911\", \"32506925\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CMKLR1-mediated PD-L1 suppression enhances anti-tumor immunity in immunocompetent models not shown\", \"Specific RvE1-derived valve-protective signaling intermediates not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Adipocyte-specific CMKLR1 deletion revealed the receptor tonically suppresses beige adipocyte IL-33 production by dampening cAMP-PKA signaling, interrupting the feed-forward loop with type 2 innate immunity required for thermogenesis; an agonist anti-ChemR23 mAb separately confirmed that receptor activation directly promotes macrophage efferocytosis and resolves chronic colitis.\",\n      \"evidence\": \"Adipocyte-specific CMKLR1 KO mice under cold exposure and HFD, cAMP/PKA/IL-33 measurement; agonist mAb in peritonitis and colitis models with efferocytosis and neutrophil apoptosis readouts\",\n      \"pmids\": [\"34330814\", \"33811066\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cAMP-PKA suppression is Gαi-mediated or involves arrestin-dependent mechanism not distinguished\", \"Agonist mAb signaling bias relative to chemerin not characterized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CMKLR1 was found to regulate lipid metabolism in clear cell renal cell carcinoma by suppressing adipose triglyceride lipase and modulating SREBP1c/CD36-mediated lipid uptake; CMKLR1 loss induced apoptosis, ferroptosis, and autophagy, revealing a metabolic dependency in lipid-laden tumors.\",\n      \"evidence\": \"siRNA/shRNA and α-NETA pharmacological inhibition, lipidomics, transcriptomics, patient-derived xenografts\",\n      \"pmids\": [\"38640229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct signaling pathway from CMKLR1 to ATGL suppression not defined\", \"Whether this lipid metabolic role applies beyond ccRCC not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis of CMKLR1's dual ligand recognition (chemerin vs. RvE1), the phosphosite-level code for biased signaling, whether CMKLR1's PTEN-stabilizing and metabolic functions are linked through a common signaling branch, and the therapeutic potential of biased agonists versus antagonists across its immune, metabolic, and oncologic roles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of CMKLR1\", \"Biased agonism at CMKLR1 not systematically profiled\", \"In vivo relevance of CMKLR1 as HIV/SIV coreceptor remains unclear\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 4, 18, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [23, 28, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 13, 18]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [13, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 8, 15, 18, 22, 26]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 5, 6, 9, 11, 13, 17, 31]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 12, 30, 35]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [26, 27, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"RARRES2\",\n      \"ARRB2\",\n      \"GRK6\",\n      \"PTEN\",\n      \"SYK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}